XML 49 R34.htm IDEA: XBRL DOCUMENT v3.24.0.1
Revenue (Tables)
 12 Months Ended
Dec. 31, 2023
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block]
The following table represents our revenues disaggregated by product line (in thousands) and our disaggregated product line revenue as a percentage of total revenue:
Year ended December 31,
202320222021
Product lineRevenue% of RevenueRevenue% of RevenueRevenue% of Revenue
Consumables$969,129 43 %$974,993 43 %$555,189 42 %
Infusion Systems629,043 28 %617,435 27 %352,321 27 %
Vital Care660,954 29 %687,569 30 %408,798 31 %
Total Revenues$2,259,126 100 %$2,279,997 100 %$1,316,308 100 %
    
We report revenue on a "where sold" basis, which reflects the revenue within the country or region in which the ultimate sale is made to our external customer.    
    
The following table represents our revenues disaggregated by geography (in thousands):
Year ended December 31,
Geography202320222021
United States$1,440,017 $1,460,069 $941,809 
Europe, the Middle East and Africa373,571 367,411 147,488 
Asia-Pacific241,699 257,208 85,692 
Other Foreign203,839 195,309 141,319 
Total Revenues$2,259,126 $2,279,997 $1,316,308 

Domestic sales accounted for 64%, 64% and 72% of total revenue in 2023, 2022 and 2021, respectively. International sales accounted for 36%, 36% and 28% of total revenue in 2023, 2022 and 2021, respectively.
Contract with Customer, Asset and Liability [Table Text Block]
Our contract balances (deferred revenue) are recorded in accrued liabilities and other long-term liabilities in our consolidated balance sheet (see Note 10: Accrued Liabilities and Other Long-term Liabilities). The following table presents the changes in our contract balances for the years ended December 31, 2023 and 2022, (in thousands):
Contract Liabilities
Beginning balance, January 1, 2022$(7,461)
Fair value of acquired deferred revenue(51,245)
Equipment revenue recognized32,252 
Equipment revenue deferred due to implementation(20,332)
Software revenue recognized16,277 
Software revenue deferred due to implementation(17,557)
Government grant deferred revenue(3,729)
Government grant recognized1,514 
Other deferred revenue(1,500)
Other deferred revenue recognized5,915 
Ending balance, December 31, 2022(45,866)
Equipment revenue recognized34,121 
Equipment revenue deferred due to implementation(35,868)
Software revenue recognized18,526 
Software revenue deferred due to implementation(19,947)
Government grant deferred revenue(944)
Government grant recognized3,684 
Other deferred revenue(1,924)
Other deferred revenue recognized6,041 
Ending balance, December 31, 2023$(42,177)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction
As of December 31, 2023, revenue from remaining performance obligations is as follows (in thousands):

Recognition Timing
<12 Months> 12 Months
Equipment revenue$(17,749)$(24)
Software revenue(10,062)(763)
Government grant revenue(1)
(2,064)(9,415)
Other deferred revenue(2)
(1,717)(383)
Total$(31,592)$(10,585)